Literature DB >> 16338127

Endosomal proteases in antigen presentation.

Harold A Chapman1.   

Abstract

Processing of cytoplasmic and endocytized foreign antigens were once thought to be completely separate pathways of peptide generation for MHC class I and class II peptide display. However, recent studies show actually that there is extensive overlap owing, in part, to the positioning of endosomal proteases at sites in which MHC class I and class II paths cross. The questions of how antigens access and persist at sites of endosomal processing are proving to be as important as those regarding the proteases themselves. However, individual proteases within the set of endosomal enzymes have emerged both as targets for microbial evasion from MHC-class-II-dependent immunity and as required elements in autoimmunity. Repeated implication of cathepsins in processing medically important antigens holds promise for therapeutic manipulation of proteases in diseases in which there is disordered adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338127     DOI: 10.1016/j.coi.2005.11.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

Review 1.  The role of cystatins in tick physiology and blood feeding.

Authors:  Alexandra Schwarz; James J Valdés; Michalis Kotsyfakis
Journal:  Ticks Tick Borne Dis       Date:  2012-04-20       Impact factor: 3.744

2.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

3.  Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.

Authors:  Eric M Jacobson; Heyi Yang; Francesca Menconi; Rong Wang; Roman Osman; Luce Skrabanek; Cheuk Wun Li; Mohammed Fadlalla; Alisha Gandhi; Vijaya Chaturvedi; Eric P Smith; Sandy Schwemberger; Andrew Osterburg; George F Babcock; Yaron Tomer
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

4.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

5.  Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation.

Authors:  Rajnish Kumar; Michael Tuen; Hualin Li; Doris B Tse; Catarina E Hioe
Journal:  Vaccine       Date:  2011-09-23       Impact factor: 3.641

6.  Characterization of human astrovirus cell entry.

Authors:  Ernesto Méndez; Claudia Muñoz-Yañez; Claudia Sánchez-San Martín; Gabriela Aguirre-Crespo; M del Rocio Baños-Lara; Michelle Gutierrez; Rafaela Espinosa; Yunuén Acevedo; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

Review 7.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 8.  Autophagy and ethanol-induced liver injury.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Modulation of dendritic cell function and immune response by cysteine protease inhibitor from murine nematode parasite Heligmosomoides polygyrus.

Authors:  Yanxia Sun; Guiyun Liu; Zhaotao Li; Yue Chen; Yunfeng Liu; Boyu Liu; Zhong Su
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

10.  Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.

Authors:  Maurice Jabbour; Erin M Campbell; Hanna Fares; Lonnie Lybarger
Journal:  J Immunol       Date:  2009-10-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.